Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 8 studies | 25% ± 9% | |
glutamatergic neuron | 7 studies | 31% ± 19% | |
endothelial cell | 5 studies | 25% ± 8% | |
retinal ganglion cell | 5 studies | 47% ± 27% | |
GABAergic neuron | 5 studies | 36% ± 19% | |
neuron | 4 studies | 21% ± 6% | |
interneuron | 4 studies | 40% ± 22% | |
astrocyte | 3 studies | 30% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 31% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 11395.78 | 2642 / 2642 | 100% | 107.29 | 705 / 705 |
kidney | 99% | 3779.82 | 88 / 89 | 100% | 56.32 | 900 / 901 |
adrenal gland | 100% | 4648.41 | 258 / 258 | 99% | 64.30 | 227 / 230 |
prostate | 99% | 4668.89 | 243 / 245 | 99% | 29.81 | 498 / 502 |
thymus | 99% | 3231.02 | 647 / 653 | 99% | 31.31 | 600 / 605 |
liver | 99% | 4272.75 | 224 / 226 | 99% | 42.43 | 402 / 406 |
breast | 100% | 5209.47 | 459 / 459 | 97% | 31.69 | 1086 / 1118 |
lung | 99% | 4398.16 | 575 / 578 | 96% | 37.62 | 1111 / 1155 |
uterus | 99% | 6425.42 | 169 / 170 | 92% | 28.27 | 422 / 459 |
ovary | 100% | 5618.41 | 180 / 180 | 90% | 21.59 | 386 / 430 |
skin | 90% | 3471.04 | 1626 / 1809 | 99% | 64.09 | 469 / 472 |
intestine | 99% | 4983.45 | 957 / 966 | 88% | 17.56 | 465 / 527 |
bladder | 100% | 4912.33 | 21 / 21 | 79% | 19.48 | 400 / 504 |
stomach | 88% | 3012.25 | 317 / 359 | 87% | 19.18 | 249 / 286 |
pancreas | 77% | 1721.76 | 253 / 328 | 96% | 33.71 | 171 / 178 |
esophagus | 81% | 4259.85 | 1169 / 1445 | 86% | 18.08 | 157 / 183 |
adipose | 100% | 6061.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 61.72 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.41 | 29 / 29 |
muscle | 100% | 15827.20 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4580.20 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6853.02 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 5899.53 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 19.57 | 44 / 45 |
peripheral blood | 59% | 1614.60 | 549 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000409 | Biological process | positive regulation of T cell extravasation |
GO_0007155 | Biological process | cell adhesion |
GO_0050904 | Biological process | diapedesis |
GO_2000391 | Biological process | positive regulation of neutrophil extravasation |
GO_0009986 | Cellular component | cell surface |
GO_0005912 | Cellular component | adherens junction |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0005515 | Molecular function | protein binding |
Gene name | CD99L2 |
Protein name | CD99 antigen-like protein 2 (MIC2-like protein 1) (CD antigen CD99) CD99 antigen-like protein 2 |
Synonyms | MIC2L1 UNQ1964/PRO4486 |
Description | FUNCTION: Plays a role in a late step of leukocyte extravasation helping cells to overcome the endothelial basement membrane. Acts at the same site as, but independently of, PECAM1 (By similarity). Homophilic adhesion molecule, but these interactions may not be required for cell aggregation (By similarity). . |
Accessions | ENST00000346693.8 [Q8TCZ2-4] A0A0S2Z5R8 Q96E20 ENST00000418547.2 ENST00000437787.6 [Q8TCZ2-6] ENST00000355149.8 [Q8TCZ2-3] ENST00000466436.5 [Q8TCZ2-2] H0Y4H3 A0A0U1RQT8 ENST00000634795.1 A0A024RC16 ENST00000370377.8 [Q8TCZ2-1] Q8TCZ2 |